KPTI icon

Karyopharm Therapeutics
KPTI

Overview Fund Trends Analyst Outlook Journalist POV

54 hedge funds and large institutions have $204M invested in Karyopharm Therapeutics in 2013 Q4 according to their latest regulatory filings, with 54 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
54
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$53.8M
2
+$19.8M
3
+$18M
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$11.6M
5
AllianceBernstein
AllianceBernstein
Tennessee
+$10.4M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$802K
27
$756K
28
$678K
29
$662K
30
$617K
31
$595K
32
$553K
33
$492K
34
$471K
35
$458K
36
$455K
37
$425K
38
$385K
39
$325K
40
$292K
41
$253K
42
$234K
43
$221K
44
$119K
45
$112K
46
$88K
47
$71K
48
$60K
49
$31K
50
$29K
1
2
3